For US HCP Use Only

Connect with a hematologist/oncologist with AML expertise

AML is a heterogeneous disease. Management of AML can be challenging. Per NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for AML, consultation with a high-volume tertiary care or academic medical center is recommended.1 Ultimately, connecting with an AML expert may help offer patients a chance at improved patient care.

Find an expert* who specializes in AML

T&C Help Text

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RESULTS FOUND

If you are a healthcare provider and would like to add your practice to this list, opt out, or update your profile information, please contact AMLExpertLocatorSupport@abbvie.com.

*PLEASE NOTE: While we update our directory regularly, this list may not have current provider information. This is an AbbVie Inc.-compiled list of expert prescribers as determined by their involvement with top congresses and institutions, treatment of acute myeloid leukemia and adherence to prescribing and management guidelines. The results shown may not be inclusive of all providers who are considered to be experts in your area.

Learn more about a 1L AML treatment option

Explore treatment

Reference: 1. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Acute Myeloid Leukemia V.3.2026. © National Comprehensive Cancer Network, Inc. 2025. All rights reserved. Accessed November 24, 2025. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.